WebMar 2, 2016 · However, co-culture in vitro experiments and co-implantation in vivo experiments showed that the combination of low doses of cisplatin (10 μM) and low doses of pirfenidone (0.5 mg/mL), in both CAFs and tumors, lead to increased cell death and decreased tumor progression, respectively. WebThe clinical and histopathological data as well as the lack of an infectious cause indicate that pulmonary fibrosis was induced by oxaliplatin and 5-FU/folinic acid. Conclusion: This case demonstrates that treatment with oxaliplatin and 5-FU/folinic acid can cause acute pulmonary fibrosis.
The anti-fibrotic agent pirfenidone synergizes with cisplatin in ...
WebSep 1, 2024 · Cisplatin for injection, USP, a platinum-based drug for intravenous use, is a white to light yellow lyophilized powder. Each vial of Cisplatin for injection, USP contains 50 mg Cisplatin, 450 mg Sodium Chloride, USP, and 500 mg Mannitol, USP. Cisplatin for Injection, USP may contain hydrochloric acid for pH adjustment. WebSome of the more common medication types that are known to carry the risk of pulmonary fibrosis include certain: antibiotics, particularly nitrofurantoin immunosuppressant drugs, such as methotrexate drugs for heart conditions, particularly amiodarone cancer chemotherapy drugs biological agents used to treat cancer or immune disorders. boston fans store
Increased pulmonary toxicity with bleomycin and cisplatin …
WebPulmonary toxicity is one of the most serious adverse effects associated with a quick course of vincristine, bleomycin, and cisplatin neoadjuvant chemotherapy (NAC-VBP). The aim of this study was to evaluate pulmonary toxicity related to a quick course NAC-VBP. WebNov 26, 2024 · Ginkgolic C17:1 or cisplatin alone inhibited the PI3K/AKT/mTOR pathway in hepatoblastoma HepG2 cells, and co-treatment exhibited an enhanced inhibitory effect, while in normal hepatocytes, ginkgolic C17:1 alone did not significantly impact this signaling pathway, rather reducing cisplatin-caused inhibition to prevent cell damage [ 43 ]. WebMar 8, 2024 · Cisplatin is implicated in promoting lung fibrosis, which indicates that IPF fibroblasts cultured on a collagen matrix are resistant to cisplatin-induced cell death. To test this, we first treated non-IPF and IPF fibroblasts (n = 8 each) with various doses of cisplatin, and their viability was measured. hawk graphics